Vaccination programs for older adults in an era of demographic change
- PMID: 29887922
- PMCID: PMC5972173
- DOI: 10.1007/s41999-018-0040-8
Vaccination programs for older adults in an era of demographic change
Abstract
Objectives: Populations are aging worldwide. This paper summarizes some of the challenges and opportunities due to the increasing burden of infectious diseases in an aging population.
Results: Older adults typically suffer elevated morbidity from infectious disease, leading to increased demand for healthcare resources and higher healthcare costs. Preventive medicine, including vaccination can potentially play a major role in preserving the health and independence of older adults. However, this potential of widespread vaccination is rarely realized. Here, we give a brief overview of the problem, discuss concrete obstacles and the potential for expanded vaccination programs to promote healthy aging.
Conclusion: The increasing healthcare burden of infectious diseases expected in aging populations could, to a large extent, be reduced by achieving higher vaccination coverage among older adults. Vaccination can thus contribute to healthy aging, alongside healthy diet and physical exercise. The available evidence indicates that dedicated programs can achieve substantial improvements in vaccination coverage among older adults, but more research is required to assess the generalizability of the results achieved by specific interventions (see Additional file 1).
Keywords: Demographic change; Healthy aging; Vaccination programs; Vaccines.
Conflict of interest statement
Compliance with ethical standardsGDG, ADP, RSO and MD are employees of the GSK group of companies. ADP, RSO and MD hold restricted shares in the GSK group of companies. MC received personal fees from the GSK group of companies. JEM is an employee of The Health Sciences North Research Institute and her institution received an honorarium from the GSK group of companies for her attendance at an advisory board meeting and she received travel reimbursement during the conduct of this work and outside this work. PHL, BGL and JF have nothing to disclose. EW received consulting fees from Alios Pharmaceuticals outside this work. JG received grants from NIH during the conduct of this work and received personal fees from the GSK group of companies for his attendance at an advisory board meeting during the conduct of this work. SM received personal fees from the GSK group of companies for her participation in a vaccine workshop in Brussels, Belgium, in February 2016 outside this work and received a grant from Takeda outside this work. WS received a grant from Centers for Disease Control and Prevention during the conduct of this work. WS also received personal fees from Merck, Pfizer, Genentech, Dynavax and Novavax during the conduct of this work. HN received personal fees from the GSK group of companies for his attendance at an advisory board meeting during the conduct of this work and received personal fees from Pfizer and MSD outside of this work.All procedures performed in this study were in accordance with the ethical standards.For a literature review, written consent is not required.
Figures


References
-
- Suhrcke M, McKee M, Sauto Arce R, Tsolova S, Mortensen J. The contribution of health to the economy in the European Union. European Communities, Luxembourg 2005. https://ec.europa.eu/health/archive/ph_overview/documents/health_economy.... Last accessed 6 Feb 2018 - PubMed
-
- European Commission, Directorate-General for Economic and Financial Affairs. Sustainability Report. Brussels, 2009. http://ec.europa.eu/economy_finance/publications/pages/publication15998_.... Last accessed 6 Feb 2018
-
- World Health Organization. WHO report on healthy aging. Geneva 2015. http://apps.who.int/iris/bitstream/10665/186463/1/9789240694811_eng.pdf. Last accessed 6 Feb 2018
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources